These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6729842)

  • 1. In vivo reconstitution of ricin-like activity from its A and B chain subunits.
    Cushley W; Muirhead MJ; Silva F; Greathouse J; Tucker T; Uhr JW; Vitetta ES
    Toxicon; 1984; 22(2):265-77. PubMed ID: 6729842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of ricin A1, A2, and B chains and characterization of their toxicity.
    Fulton RJ; Blakey DC; Knowles PP; Uhr JW; Thorpe PE; Vitetta ES
    J Biol Chem; 1986 Apr; 261(12):5314-9. PubMed ID: 3957927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The preparation of deglycosylated ricin by recombination of glycosidase-treated A- and B-chains: effects of deglycosylation on toxicity and in vivo distribution.
    Foxwell BM; Blakey DC; Brown AN; Donovan TA; Thorpe PE
    Biochim Biophys Acta; 1987 Jan; 923(1):59-65. PubMed ID: 3099852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of the carbohydrate in ricin with metaperiodate-cyanoborohydride mixtures. Effects on toxicity and in vivo distribution.
    Thorpe PE; Detre SI; Foxwell BM; Brown AN; Skilleter DN; Wilson G; Forrester JA; Stirpe F
    Eur J Biochem; 1985 Feb; 147(1):197-206. PubMed ID: 2982609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and properties of immunotoxins containing one vs. two deglycosylated ricin A chains.
    Ghetie V; Swindell E; Uhr JW; Vitetta ES
    J Immunol Methods; 1993 Nov; 166(1):117-22. PubMed ID: 8228282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renaturated ricin toxin B chain made in Escherichia coli is soluble, stable, and biologically active.
    Tonevitsky A; Toptygin A; Agapov I; Pfueller U; Frankel A
    Biochem Mol Biol Int; 1994 Apr; 32(6):1139-46. PubMed ID: 8061631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of Sepharose-unbinding ricin from castor beans (Ricinus communis) by hydroxyapatite chromatography.
    Woo BH; Lee JT; Lee KC
    Protein Expr Purif; 1998 Jul; 13(2):150-4. PubMed ID: 9675056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The disulfide bond connecting the chains of ricin.
    Lappi DA; Kapmeyer W; Beglau JM; Kaplan NO
    Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1096-100. PubMed ID: 274699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological characteristics associated with the protective efficacy of antibodies to ricin.
    Maddaloni M; Cooke C; Wilkinson R; Stout AV; Eng L; Pincus SH
    J Immunol; 2004 May; 172(10):6221-8. PubMed ID: 15128810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic effect of anti-Mr 67,000 protein immunotoxins on human tumors in a nude mouse model.
    Weil-Hillman G; Runge W; Jansen FK; Vallera DA
    Cancer Res; 1985 Mar; 45(3):1328-36. PubMed ID: 3971376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of four CD22 antibodies as ricin A chain-containing immunotoxins for the in vivo therapy of human B-cell leukemias and lymphomas.
    Shen GL; Li JL; Ghetie MA; Ghetie V; May RD; Till M; Brown AN; Relf M; Knowles P; Uhr JW
    Int J Cancer; 1988 Nov; 42(5):792-7. PubMed ID: 3263328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Processing of preproricin in transgenic tobacco.
    Sehnke PC; Ferl RJ
    Protein Expr Purif; 1999 Mar; 15(2):188-95. PubMed ID: 10049674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and in vitro and in vivo activity of a hybrid composed of ricin B chain-barley ribosome-inactivating protein.
    Ovadia M; Wiley RG; Hager C; LaRocca C; Oeltmann TN
    Arch Biochem Biophys; 1988 Jul; 264(1):168-75. PubMed ID: 3164992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An investigation of the degradation of the plant toxin, ricin, by sodium hypochlorite.
    Mackinnon PJ; Alderton MR
    Toxicon; 2000 Feb; 38(2):287-91. PubMed ID: 10665808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunoassay of ricin A- and B-chains applied to samples of ricin A-chain prepared by chromatofocusing and by DEAE Bio-Gel A chromatography.
    Ramakrishnan S; Eagle MR; Houston LL
    Biochim Biophys Acta; 1982 Nov; 719(2):341-8. PubMed ID: 7150646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteolytic processing of ricin A chain is not required for cytotoxicity.
    Argent RH; Roberts LM; Lord JM
    Biochem Biophys Res Commun; 1997 Dec; 241(3):617-21. PubMed ID: 9434757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preproricin expressed in Nicotiana tabacum cells in vitro is fully processed and biologically active.
    Tagge EP; Chandler J; Harris B; Czako M; Marton L; Willingham MC; Burbage C; Afrin L; Frankel AE
    Protein Expr Purif; 1996 Aug; 8(1):109-18. PubMed ID: 8812841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical studies on oral toxicity of ricin. IV. A fate of orally administered ricin in rats.
    Ishiguro M; Tanabe S; Matori Y; Sakakibara R
    J Pharmacobiodyn; 1992 Apr; 15(4):147-56. PubMed ID: 1494977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors.
    Scott CF; Goldmacher VS; Lambert JM; Jackson JV; McIntyre GD
    J Natl Cancer Inst; 1987 Nov; 79(5):1163-72. PubMed ID: 3500356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergy between immunotoxins prepared with native ricin A chains and chemically-modified ricin B chains.
    Vitetta ES
    J Immunol; 1986 Mar; 136(5):1880-7. PubMed ID: 2419417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.